LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Novel coronavirus infection and Kawasaki disease.

    Bitsadze, V O / Grigoreva, K / Khizroeva, J Kh / Pervunina, T M / Tsibizova, V I / Tretyakova, M V / Makatsariya, A D

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

    2020  Volume 35, Issue 16, Page(s) 3044–3048

    Abstract: There is a global problem of increment of the number of children with clinical features that mimic Kawasaki Disease (KD) during the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. The disease was first reported by Tomisaku Kawasaki, a Japanese ... ...

    Abstract There is a global problem of increment of the number of children with clinical features that mimic Kawasaki Disease (KD) during the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. The disease was first reported by Tomisaku Kawasaki, a Japanese pediatrician, in a four-year-old child with a rash and fever at the Red Cross Hospital in Tokyo in January 1961. Now Kawasaki disease is recognized worldwide. The complexity of symptoms was defined as an «acute febrile mucocutaneous lymphnode syndrome". At the moment, it is still unclear whether the coronavirus itself can lead to development of mucocutaneous lymph node syndrome. However, it is believed that COVID-19 virus infection worsens the course of Kawasaki disease, and in some cases, children affected by SARS-V-2 may develop a disease that has a clinical picture similar to Kawasaki disease.
    MeSH term(s) COVID-19/complications ; Child ; Child, Preschool ; Fever ; Humans ; Mucocutaneous Lymph Node Syndrome/complications ; Mucocutaneous Lymph Node Syndrome/diagnosis ; Mucocutaneous Lymph Node Syndrome/epidemiology ; Pandemics ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-07-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 2077261-0
    ISSN 1476-4954 ; 1057-0802 ; 1476-7058
    ISSN (online) 1476-4954
    ISSN 1057-0802 ; 1476-7058
    DOI 10.1080/14767058.2020.1800633
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 3510: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article: Novel coronavirus infection and Kawasaki disease

    Bitsadze, V O / Grigoreva, K / Khizroeva, J Kh / Pervunina, T M / Tsibizova, V I / Tretyakova, M V / Makatsariya, A D

    J Matern Fetal Neonatal Med

    Abstract: There is a global problem of increment of the number of children with clinical features that mimic Kawasaki Disease (KD) during the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. The disease was first reported by Tomisaku Kawasaki, a Japanese ... ...

    Abstract There is a global problem of increment of the number of children with clinical features that mimic Kawasaki Disease (KD) during the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. The disease was first reported by Tomisaku Kawasaki, a Japanese pediatrician, in a four-year-old child with a rash and fever at the Red Cross Hospital in Tokyo in January 1961. Now Kawasaki disease is recognized worldwide. The complexity of symptoms was defined as an «acute febrile mucocutaneous lymphnode syndrome". At the moment, it is still unclear whether the coronavirus itself can lead to development of mucocutaneous lymph node syndrome. However, it is believed that COVID-19 virus infection worsens the course of Kawasaki disease, and in some cases, children affected by SARS-V-2 may develop a disease that has a clinical picture similar to Kawasaki disease.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #690285
    Database COVID19

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  3. Article: Coronavirus disease (COVID-19) and disseminated intravascular coagulation

    Makatsariya, A. D. / Grigorieva, K. N. / Mingalimov, M. A. / Bitsadze, V. O. / Khizroeva, J. Kh / Tretyakova, M. V. / Elalamy, I. / Shkoda, A. S. / Nemirovskiy, V. B. / Blinov, D. V. / Mitryuk, D. V.

    Obstetrics, Gynecology and Reproduction

    Abstract: COVID-19 is an infectious disease caused by the beta-coronavirus SARS-CoV-2 that in 2020 has spread worldwide In most severe patients, the clinical picture begins with respiratory failure further deteriorating up to multiple organ failure Development of ... ...

    Abstract COVID-19 is an infectious disease caused by the beta-coronavirus SARS-CoV-2 that in 2020 has spread worldwide In most severe patients, the clinical picture begins with respiratory failure further deteriorating up to multiple organ failure Development of coagulopathy is the most adverse prognostic Analyzing currently available clinical data revealed that 71 4 % and 0 6 % of survivors and fatal cases, respectively, demonstrated signs of overt disseminated intravascular coagulation (DIC) Monitoring D-dimer level, prothrombin time, platelet count and fibrinogen content is important for determining indications for treatment and hospitalization in COVID-19 patients In case such parameters deteriorate, a more pro-active “aggressive” intensive care should be applied Low molecular weight heparin (LMWH) should be administered to all patients with diagnosed COVID-19 infection (including non-critical patients) requiring hospitalization, but having no contraindications to LMWH
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #841175
    Database COVID19

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  4. Article: Pregnancy and Zika virus

    Startseva, T. V. / Kanshina, N. N. / Tretyakova, M. V. / Bitsadze, V. O. / Khizroeva, J. Kh / Radetskaya, L. S. / Stuleva, N. S. / Tsibizova, V. I. / Shkoda, A. S. / Blinov, D. V. / Makatsariya, A. D.

    Obstetrics, Gynecology and Reproduction

    Abstract: Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the genus Flavivirus and the Flaviviridae family In 1947 and 1948 ZIKV was first isolated from a nonhuman primate as well as from mosquitoes in Africa, respectively For half a century, ZIKV ... ...

    Abstract Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the genus Flavivirus and the Flaviviridae family In 1947 and 1948 ZIKV was first isolated from a nonhuman primate as well as from mosquitoes in Africa, respectively For half a century, ZIKV infections in human were sporadic prior to 2015-2016 pandemic spreading Transmission of ZIKV from mother to fetus can occur in any trimester of pregnancy, even if mother was an asymptomatic carrier The clinical signs of ZIKV infection are nonspecific and can be misdiagnosed as some other infectious diseases, especially those caused by arboviruses such as Dengue and Chikungunya ZIKV infection was solely associated with mild illness prior to the large French Polynesian and Brazil outbreaks, when severe neurological complications, Guillain-Barre syndrome and dramatically increased rate of severe congenital malformations (including microcephaly) were reported The adaptation of ZIKV to an urban cycle in endemic areas suggests that the incidence of ZIKV infections may be underestimated The pandemic of novel coronavirus infection (COVID-19) demonstrates that lessons from ZIKV pandemic propagation has not been learned properly © 2020 Universidad de Antioquia All rights reserved
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #831744
    Database COVID19

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  5. Article: Laboratory monitoring of COVID-19 patients and importance of coagulopathy markers

    Khizroeva, J. Kh / Makatsariya, A. D. / Bitsadze, V. O. / Tretyakova, M. V. / Slukhanchuk, E. V. / Elalamy, I. / Gris, J. C. / Radetskaya, L. S. / Makatsariya, N. A. / Sulina, Y. Yu / Tsibizova, V. I. / Shkoda, A. S. / Blinov, D. V.

    Obstetrics, Gynecology and Reproduction

    Abstract: The pandemic of a novel coronavirus infection COVID-19 has become a real challenge to the mankind and medical community and has raised a number of medical and social issues Based on the currently available information on COVID-19 clinical cases, it ... ...

    Abstract The pandemic of a novel coronavirus infection COVID-19 has become a real challenge to the mankind and medical community and has raised a number of medical and social issues Based on the currently available information on COVID-19 clinical cases, it follows that COVID-19 patients in critical condition exhibit a clinical picture of disseminated intravascular coagulation (DIC), septic shock with developing multiple organ failure, which justifies use of anticoagulant therapy in COVID-19 patients In addition to isolating virus RNA from biological material and polymerase chain reaction diagnostics, use of simple and easily accessible laboratory blood markers is necessary for management of COVID-19 patients If the activation of coagulation processes is sufficient enough, consumption of platelets and blood clotting factors can be diagnosed by laboratory methods as prolongation of routine blood clotting tests and increasing thrombocytopenia Hyperfibrinogenemia, increased D-dimer level, prolonged prothrombin time, thrombocytopenia, lymphopenia, leukocytopenia, increased concentration of interleukin-6 and ferritin are observed in most COVID-19 patients The degree of increase in these changes correlates with severity of the inflammatory process and serves as a prognostically unfavorable sign Here we discuss value of laboratory monitoring playing an essential role in such pathological crisis that contributes to patient screening, diagnosis as well as further monitoring, treatment and rehabilitation
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #842276
    Database COVID19

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  6. Article: Novel coronavirus infection (COVID-19) and risk groups in obstetrics and gynecology

    Makatsariya, A. D. / Bitsadze, V. O. / Khizroeva, J. Kh / Solopova, A. G. / Vorobyov, A. V. / Stuleva, N. S. / Akinshina, S. V. / Makatsariya, N. A. / Tretyakova, M. V. / Elalamy, I. / Gris, J. C. / Rizzo, G. / Nemirovskiy, V. B. / Kapanadze, D. L. / Mitryuk, D. V. / Blinov, D. V.

    Obstetrics, Gynecology and Reproduction

    Abstract: Dear editors of Obstetrics, Gynecology and Reproduction Journal! Due to the particular urgency of the problem of managing patients with a new coronavirus infection (COVID-19), we are sending a letter outlining our position on this ... ...

    Abstract Dear editors of Obstetrics, Gynecology and Reproduction Journal! Due to the particular urgency of the problem of managing patients with a new coronavirus infection (COVID-19), we are sending a letter outlining our position on this issue
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #841227
    Database COVID19

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  7. Article: Regarding the evidence-based use of micronized progesterone

    Makatsariya, A. D. / Di Renzo, G. C. / Rizzo, G. / Bitsadze, V. O. / Khizroeva, J. Kh Blinov D. V. / Vovk, E. I. / Govorov, I. E. / Guryev, D. L. / Dikke, G. B. / Zainulina, M. S. / Zakharova, N. S. / Kovalev, V. V. / Komlichenko, E. V. / Kramarskiy, V. A. / Loginov, A. B. / Maltseva, L. I. / Nemirovskiy, V. B. / Ponomarev, D. A. / Rudakova, E. B. /
    Samburova, N. V. / Serova, O. F. / Tetelyutina, F. K. / Tretyakova, M. V. / Ungiadze, J. Yu Tsibizova V. I.

    Obstetrics, Gynecology and Reproduction

    Abstract: An issue of habitual miscarriage poses a high social importance especially during COVID-19 pandemic Meanwhile, healthcare workers faced a mass media campaign against using micronized progesterone upon habitual miscarriage, which, as viewed by us, ... ...

    Abstract An issue of habitual miscarriage poses a high social importance especially during COVID-19 pandemic Meanwhile, healthcare workers faced a mass media campaign against using micronized progesterone upon habitual miscarriage, which, as viewed by us, displays signs of prejudiced data manipulation and may disorient practitioners In this Letter we provide objective information on accumulated data regarding gestagenes efficacy and safety We invoke healthcare professionals to make decisions deserving independent primary source trust presented by original scientific papers published in peer-reviewed journals, clinical recommendations proposed by professional medical communities as well as treatment standards and protocols
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #903106
    Database COVID19

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top